To better identify tumors with HRD, Edward Schaeffer, MD, Adam Weiner, MD, and a team of investigators developed a transcriptomic signature for HRD in PCa (HRD-P). Publication link: https://t.co/ydjcYMbDqS
A transcriptomic model for homologous recombination deficiency in #prostatecancer. #PCa https://t.co/fZ1FvKPqfN
RT @Adam_Weiner535: Just out in @pcan_journal 🚨 By analyzing >8k #prostatecancer samples, our group suggests transcriptomics can augment o…
RT @Adam_Weiner535: Just out in @pcan_journal 🚨 By analyzing >8k #prostatecancer samples, our group suggests transcriptomics can augment o…
RT @Adam_Weiner535: Just out in @pcan_journal 🚨 By analyzing >8k #prostatecancer samples, our group suggests transcriptomics can augment o…
RT @Adam_Weiner535: Just out in @pcan_journal 🚨 By analyzing >8k #prostatecancer samples, our group suggests transcriptomics can augment o…
RT @Adam_Weiner535: Just out in @pcan_journal 🚨 By analyzing >8k #prostatecancer samples, our group suggests transcriptomics can augment o…
RT @Adam_Weiner535: Just out in @pcan_journal 🚨 By analyzing >8k #prostatecancer samples, our group suggests transcriptomics can augment o…
RT @Adam_Weiner535: Just out in @pcan_journal 🚨 By analyzing >8k #prostatecancer samples, our group suggests transcriptomics can augment o…
Just out in @pcan_journal 🚨 By analyzing >8k #prostatecancer samples, our group suggests transcriptomics can augment our ability to ID patients with HRD+ tumors @NM_Urology @LurieCancer @Davicioni @DrSpratticus @EdwardSchaeffer @LotanLab https://t.co
Dr. @EdwardSchaeffer alongside @NM_Urology and @UMich collaborators developed a transcriptomic signature for homologous recombination deficiency in #ProstateCancer. Check out their findings: https://t.co/QPxYleb2ER 👈 https://t.co/jOZRnzzfrm
New article: A transcriptomic model for homologous recombination deficiency in prostate cancer https://t.co/q7DPu6fLQs #prostatecancer #oncology https://t.co/Huj8frA41r